BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11774263)

  • 1. Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.
    Maubant S; Cruet-Hennequart S; Poulain L; Carreiras F; Sichel F; Luis J; Staedel C; Gauduchon P
    Int J Cancer; 2002 Jan; 97(2):186-94. PubMed ID: 11774263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface overexpression of alphavbeta5 integrin impedes alphavbeta3-mediated migration of the human ovarian adenocarcinoma cell line IGROV1.
    Maubant S; Leroy-Dudal J; Carreiras F; Deslandes E; Duigou F; Staedel C; Gauduchon P
    Cell Biol Int; 2007 Feb; 31(2):109-18. PubMed ID: 17074516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of alphavbeta 3 integrin and disruption of endothelial fibronectin network during the adhesion of the human ovarian adenocarcinoma cell line IGROV1 on the human umbilical vein cell extracellular matrix.
    Carreiras F; Thiébot B; Leroy-Dudal J; Maubant S; Breton MF; Darbeida H
    Int J Cancer; 2002 Jun; 99(6):800-8. PubMed ID: 12115480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10.
    Le Moguen K; Lincet H; Deslandes E; Hubert-Roux M; Lange C; Poulain L; Gauduchon P; Baudin B
    Proteomics; 2006 Oct; 6(19):5183-92. PubMed ID: 16941573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of the alpha v beta 3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1.
    Carreiras F; Lehmann M; Sichel F; Marvaldi J; Gauduchon P; Le Talaer JY
    Int J Cancer; 1995 Nov; 63(4):530-6. PubMed ID: 7591263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells.
    Gong TT; Liu XD; Zhan ZP; Wu QJ
    Exp Cell Res; 2020 Aug; 393(2):112061. PubMed ID: 32437713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
    Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
    Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment.
    Le Moguen K; Lincet H; Marcelo P; Lemoisson E; Heutte N; Duval M; Poulain L; Vinh J; Gauduchon P; Baudin B
    Proteomics; 2007 Nov; 7(22):4090-101. PubMed ID: 17994630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.
    Kellouche S; Fernandes J; Leroy-Dudal J; Gallet O; Dutoit S; Poulain L; Carreiras F
    Tumour Biol; 2010 Apr; 31(2):129-39. PubMed ID: 20358426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion of human ovarian adenocarcinoma IGROV1 cells to endothelial cells is partly mediated by the alphav integrins-vitronectin adhesive system and induces an alteration of endothelial integrity.
    Leroy-Dudal J; Heyman L; Gauduchon P; Carreiras F
    Cell Biol Int; 2005 Jun; 29(6):482-8. PubMed ID: 15914035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
    Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
    Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
    Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
    Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
    Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of chemoresistance in a human ovarian carcinoma cell is linked to a defect in cell cycle control.
    Poulain L; Lincet H; Duigou F; Deslandes E; Sichel F; Gauduchon P; Staedel C
    Int J Cancer; 1998 Nov; 78(4):454-63. PubMed ID: 9797134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells.
    Wantoch von Rekowski K; König P; Henze S; Schlesinger M; Zawierucha P; Januchowski R; Bendas G
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J
    Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells.
    Cruet-Hennequart S; Maubant S; Luis J; Gauduchon P; Staedel C; Dedhar S
    Oncogene; 2003 Mar; 22(11):1688-702. PubMed ID: 12642872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ovarian adenocarcinoma cells synthesize vitronectin and use It to organize their adhesion.
    Carreiras F; Cruet S; Staedel C; Sichel F; Gauduchon P
    Gynecol Oncol; 1999 Mar; 72(3):312-22. PubMed ID: 10053101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells.
    Ortega R; Moretto P; Fajac A; Benard J; Llabador Y; Simonoff M
    Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):77-88. PubMed ID: 8833669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelial vitronectin stimulates migration of ovarian cancer cells.
    Heyman L; Leroy-Dudal J; Fernandes J; Seyer D; Dutoit S; Carreiras F
    Cell Biol Int; 2010 Apr; 34(5):493-502. PubMed ID: 20121701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.